Supernus Pharmaceuticals reported $1.69B in Market Capitalization this August of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 190.24B 17B
Aerie Pharmaceuticals AERI:US $ 0.36B 0.08B
Ani Pharmaceuticals ANIP:US $ 0.51B 0.03B
Aurora Cannabis Inc ACB:CN 1.12B 240.7M
Bristol Myers Squibb BMY:US $ 163.94B 8.45B
Canopy Growth Corp WEED:CN C$ 1.6B 2.13B
Cara Therapeutics CARA:US $ 0.49B 0.16B
Corcept Therapeutics CORT:US $ 2.53B 0.14B
Eisai 4523:JP 1697.85B 16.31B
Eli Lilly And LLY:US $ 308.07B 35.35B
Endo International Ordinary Shares ENDP:US 0.11B 0.43B
Horizon Pharma HZNP:US 18.34B 5.81B
Lannett LCI:US $ 0.03B 0.04B
Marinus Pharmaceuticals MRNS:US $ 0.18B 0.17B
Pacira Pharmaceuticals PCRX:US $ 2.65B 0.77B
Perrigo Ordinary Shares PRGO:US 5.46B 0.29B
Pfizer PFE:US $ 294.18B 1.79B
Revance Therapeutics RVNC:US $ 1.01B 0.39B
Supernus Pharmaceuticals SUPN:US $ 1.54B 0.18B
Teva Pharmaceutical Industries TEVA:US 8.48B 1.81B
United Therapeutics UTHR:US $ 10.67B 2.55B
Xeris Pharmaceuticals Inc XERS:US $ 0.21B 0.15B